PCV7

(redirected from Pneumococcal conjugate vaccine)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
AcronymDefinition
PCV7Pneumococcal Conjugate Vaccine
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Overall 23 (39.7%) isolates were covered by 10-valent vaccine and 26 (44.8%) by 13 valent pneumococcal conjugate vaccine. Predominant serotypes or serogroups in our population that were not being covered by both these vaccines were 13F, 10F/10C/33C and 38/25F/25A, each of these were isolated from 4 (6.9%) together constituting 20.7% non-vaccine serotypes.
The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2012;31:501-8.
Loo et al., "Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites," PLoS Medicine, vol.
Major finding: When rotavirus and pneumococcal conjugate vaccines were introduced in southern Israel, hospitalization rates for rotavirus gastroenteritis and nonrotavirus gastroenteritis dropped by 78% and 21%, respectively, in children less than 2 years old, while hospitalizations for alveolar pneumonia, which is mainly pneumococcal, and other lower respiratory tract infections unlikely to be pneumococcal fell by 46% and 7%, respectively.
Updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose.
A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.
[4.] Cohen C, von Mollendorf C, de Gouveia L, et al Effectiveness of seven-valent pneumococcal conjugate vaccine (PCV-7) against invasive pneumococcal disease in HIV-infected and -uninfected children in South Africa: A matched case-control study.
Heptavalent pneumococcal conjugate vaccine (PCV7), targeting seven of more than 90 serotypes of S.
In August 2014, the Advisory Committee on Immunization Practices (ACIP) decided to add the 13-valent pneumococcal conjugate vaccine (PCV13) to the routine immunization schedule for adults ages 65 years and older; previously, it had recommended that these patients receive only the 23-valent pneumococcal polysaccharide vaccine (PPSV23).
"The NBI is conducting an investigation into the procurement by the DOH of Pneumococcal Conjugate Vaccine 10 (PCV 10)," De Lima said a week after Health Secretary Enrique Ona took a leave of absence.
All adults who are aged 65 years or older should receive 13-valent pneumococcal conjugate vaccine routinely in series with 23-valent pneumococcal polysaccharide vaccine, according to a new recommendation from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.
Projects which he currently has responsibility for include investigational pneumococcal conjugate vaccine (V114) and cytomegalovirus vaccine (V160), both of which are in clinical trials and contributions to life cycle management for Merck's varicella vaccine franchise.
Full browser ?